Related Experiment Videos
Gene therapy for urologic cancer
Fernando A Ferrer1, Ronald Rodriguez
1Department of Pediatric Urology, Connecticut Children's Medical Center, University of Connecticut, 282 Washington Street, Hartford, CT 06106, USA. fferrer@ccmckids.org
Abstract:
Advances in molecular technology and the completion of the human genome project have ushered in a new era of medicine, that of gene therapy. In every field of medicine, investigators are developing gene therapeutics in an attempt to cure diseases. Urologic oncology is no exception. Herein, we review the current status of gene therapy for urologic malignancy. Included is an overview of advances in gene delivery systems and immunology, which are driving forces for gene therapy research. Finally, we review the current gene therapy trials and experimental approaches for urologic malignancy.
Insights
Gene therapy offers a new approach to treating urologic cancers by leveraging advances in molecular technology and the human genome project. This review covers gene delivery, immunology, and current clinical trials for urologic malignancies.
Area of Science:
- Oncology
- Genetics
- Immunology
Background:
- Molecular technology and the human genome project have enabled gene therapy.
- Gene therapeutics are being developed across all medical fields.
- Urologic oncology is exploring gene therapy for cancer treatment.
Purpose of the Study:
- To review the current status of gene therapy in urologic oncology.
- To provide an overview of advances in gene delivery and immunology.
- To discuss current gene therapy trials and experimental approaches for urologic malignancies.
Main Methods:
- Literature review of gene therapy in urologic oncology.
- Analysis of advances in gene delivery systems.
- Examination of immunological aspects relevant to gene therapy.
- Survey of ongoing gene therapy clinical trials.
Main Results:
- Gene therapy is an emerging field in urologic oncology.
- Advances in gene delivery and immunology are crucial for progress.
- Several gene therapy trials and experimental approaches are underway.
Conclusions:
- Gene therapy holds significant promise for treating urologic cancers.
- Continued research in gene delivery and immunology is essential.
- Clinical trials are vital for advancing gene therapy in urologic oncology.